Ital J Dermatol Venerol 2021 Apr 23. Epub 2021 Apr 23.
Section of Dermatology-Venereology, Department of Medical, Surgical Sciences and Neurosciences, University of Siena, Siena, Italy.
Dermatol Pract Concept 2021 Mar 8;11(2):e2021004. Epub 2021 Mar 8.
Hospital São Lucas da PUCRS, Porto Alegre, Brazil.
Rep Pract Oncol Radiother 2020 Nov-Dec;25(6):934-938. Epub 2020 Oct 1.
Department of Oncology and Radiotherapy, Charles University in Prague, Faculty of Medicine and University Hospital in Pilsen, alej Svobody 80, 304 60 Pilsen, Czech Republic.
Lymphangiosarcoma, or Stewart-Treves Syndrome (STS), is a very rare skin angiosarcoma with poor prognosis, which usually affects the upper limbs of patients who underwent breast cancer surgery, including axillary dissection followed by radiotherapy (RT). Cutaneous lymphangiosarcomas, which account for approximately 5% of all angiosarcomas, usually originate in the limb with chronic lymphedema. Lymphatic blockade is involved in the onset of STS. Read More
Lancet Oncol 2020 10;21(10):e495
Division of Hematology/Oncology, Warren Alpert Medical School at Brown University, Providence, RI, USA.
Mol Clin Oncol 2020 Nov 20;13(5):49. Epub 2020 Aug 20.
Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka 541-8567, Japan.
Angiosarcoma (AS) is a rare and aggressive tumor with high rates of local recurrence and distant metastasis. Stewart-Treves syndrome (STS) is defined as AS arising in the setting of chronic lymphedema, and is extremely uncommon in the lower abdominal wall. Eribulin mesylate (eribulin) is a non-taxane microtubule inhibitor that has been approved in Japan for treating soft tissue sarcoma. Read More